TWI748553B - Skin repairing extract, composition containing the same and use thereof - Google Patents
Skin repairing extract, composition containing the same and use thereof Download PDFInfo
- Publication number
- TWI748553B TWI748553B TW109123178A TW109123178A TWI748553B TW I748553 B TWI748553 B TW I748553B TW 109123178 A TW109123178 A TW 109123178A TW 109123178 A TW109123178 A TW 109123178A TW I748553 B TWI748553 B TW I748553B
- Authority
- TW
- Taiwan
- Prior art keywords
- extract
- skin
- lactobacillus plantarum
- product
- concentration
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 98
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 76
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 76
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 76
- 210000003491 skin Anatomy 0.000 claims abstract description 58
- 230000000694 effects Effects 0.000 claims abstract description 34
- 230000008099 melanin synthesis Effects 0.000 claims abstract description 14
- 230000000475 sunscreen effect Effects 0.000 claims abstract description 13
- 239000000516 sunscreening agent Substances 0.000 claims abstract description 13
- 239000002537 cosmetic Substances 0.000 claims abstract description 10
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 7
- 230000003647 oxidation Effects 0.000 claims abstract description 6
- 210000004927 skin cell Anatomy 0.000 claims abstract 3
- 239000000047 product Substances 0.000 claims description 80
- 238000000855 fermentation Methods 0.000 claims description 52
- 230000004151 fermentation Effects 0.000 claims description 52
- 241000894006 Bacteria Species 0.000 claims description 31
- 239000002609 medium Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 230000005764 inhibitory process Effects 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 7
- 239000006872 mrs medium Substances 0.000 claims description 5
- 239000012528 membrane Substances 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- PQFMNVGMJJMLAE-QMMMGPOBSA-N L-tyrosinamide Chemical compound NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PQFMNVGMJJMLAE-QMMMGPOBSA-N 0.000 claims 1
- 239000011148 porous material Substances 0.000 claims 1
- 230000002087 whitening effect Effects 0.000 abstract description 13
- 230000003078 antioxidant effect Effects 0.000 abstract description 11
- 239000000126 substance Substances 0.000 abstract description 5
- 230000032683 aging Effects 0.000 abstract description 4
- 230000003712 anti-aging effect Effects 0.000 abstract description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 56
- 210000004027 cell Anatomy 0.000 description 38
- 238000002835 absorbance Methods 0.000 description 34
- 238000004458 analytical method Methods 0.000 description 29
- 239000004310 lactic acid Substances 0.000 description 28
- 235000014655 lactic acid Nutrition 0.000 description 28
- 102000003425 Tyrosinase Human genes 0.000 description 24
- 108060008724 Tyrosinase Proteins 0.000 description 24
- 238000012360 testing method Methods 0.000 description 23
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 20
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 19
- 230000004083 survival effect Effects 0.000 description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 18
- 238000010586 diagram Methods 0.000 description 17
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 16
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 14
- 241000196324 Embryophyta Species 0.000 description 13
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 12
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 11
- -1 chlorofluorocarbons Substances 0.000 description 11
- 239000000463 material Substances 0.000 description 11
- 239000003963 antioxidant agent Substances 0.000 description 10
- 235000006708 antioxidants Nutrition 0.000 description 10
- 229960000271 arbutin Drugs 0.000 description 10
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 10
- 230000002000 scavenging effect Effects 0.000 description 10
- 235000019154 vitamin C Nutrition 0.000 description 10
- 239000011718 vitamin C Substances 0.000 description 10
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 9
- 229930003268 Vitamin C Natural products 0.000 description 9
- 239000003112 inhibitor Substances 0.000 description 9
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 9
- 229960004705 kojic acid Drugs 0.000 description 9
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 9
- 230000036564 melanin content Effects 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical group OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 230000007423 decrease Effects 0.000 description 8
- 210000002950 fibroblast Anatomy 0.000 description 8
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 8
- 201000001441 melanoma Diseases 0.000 description 8
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 6
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 230000008439 repair process Effects 0.000 description 6
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 208000030381 cutaneous melanoma Diseases 0.000 description 5
- 230000007760 free radical scavenging Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 230000003834 intracellular effect Effects 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 230000009759 skin aging Effects 0.000 description 5
- 201000003708 skin melanoma Diseases 0.000 description 5
- 239000000344 soap Substances 0.000 description 5
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 4
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 229940074391 gallic acid Drugs 0.000 description 4
- 235000004515 gallic acid Nutrition 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000002884 skin cream Substances 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108010062877 Bacteriocins Proteins 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 108010055717 JNK Mitogen-Activated Protein Kinases Proteins 0.000 description 3
- 102100031413 L-dopachrome tautomerase Human genes 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 102000013760 Microphthalmia-Associated Transcription Factor Human genes 0.000 description 3
- 108010050345 Microphthalmia-Associated Transcription Factor Proteins 0.000 description 3
- 108091023040 Transcription factor Proteins 0.000 description 3
- 102000040945 Transcription factor Human genes 0.000 description 3
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 3
- 101710147108 Tyrosinase inhibitor Proteins 0.000 description 3
- 235000005811 Viola adunca Nutrition 0.000 description 3
- 240000009038 Viola odorata Species 0.000 description 3
- 235000013487 Viola odorata Nutrition 0.000 description 3
- 235000002254 Viola papilionacea Nutrition 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 229910001448 ferrous ion Inorganic materials 0.000 description 3
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 3
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 235000021109 kimchi Nutrition 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 239000006072 paste Substances 0.000 description 3
- 150000002989 phenols Chemical class 0.000 description 3
- 235000021110 pickles Nutrition 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000013225 prussian blue Substances 0.000 description 3
- 238000012113 quantitative test Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 108010014402 tyrosinase-related protein-1 Proteins 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 3
- LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 2
- 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 2
- 102000005636 Cyclic AMP Response Element-Binding Protein Human genes 0.000 description 2
- 108010045171 Cyclic AMP Response Element-Binding Protein Proteins 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 102100031480 Dual specificity mitogen-activated protein kinase kinase 1 Human genes 0.000 description 2
- 101710146526 Dual specificity mitogen-activated protein kinase kinase 1 Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 102000007665 Extracellular Signal-Regulated MAP Kinases Human genes 0.000 description 2
- 108010007457 Extracellular Signal-Regulated MAP Kinases Proteins 0.000 description 2
- 229940118135 JNK inhibitor Drugs 0.000 description 2
- 239000012825 JNK inhibitor Substances 0.000 description 2
- 101710093778 L-dopachrome tautomerase Proteins 0.000 description 2
- 229940124647 MEK inhibitor Drugs 0.000 description 2
- 102000004378 Melanocortin Receptors Human genes 0.000 description 2
- 108090000950 Melanocortin Receptors Proteins 0.000 description 2
- 102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 description 2
- 101710200814 Melanotropin alpha Proteins 0.000 description 2
- 208000009795 Microphthalmos Diseases 0.000 description 2
- 229940099471 Phosphodiesterase inhibitor Drugs 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 101710173693 Short transient receptor potential channel 1 Proteins 0.000 description 2
- 101710173694 Short transient receptor potential channel 2 Proteins 0.000 description 2
- LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000001273 butane Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- DCYOBGZUOMKFPA-UHFFFAOYSA-N iron(2+);iron(3+);octadecacyanide Chemical compound [Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] DCYOBGZUOMKFPA-UHFFFAOYSA-N 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 229960004502 levodopa Drugs 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 201000010478 microphthalmia Diseases 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000002571 phosphodiesterase inhibitor Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 229960003351 prussian blue Drugs 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000012247 sodium ferrocyanide Nutrition 0.000 description 2
- 239000008234 soft water Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- ZTOJFFHGPLIVKC-UHFFFAOYSA-N 3-ethyl-2-[(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C1=NN=C1SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 description 1
- 238000009020 BCA Protein Assay Kit Methods 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 101800001751 Melanocyte-stimulating hormone alpha Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 102100023482 Mitogen-activated protein kinase 14 Human genes 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 102100027467 Pro-opiomelanocortin Human genes 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000947 anti-immunosuppressive effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000003236 bicinchoninic acid assay Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 238000003570 cell viability assay Methods 0.000 description 1
- 238000013043 cell viability test Methods 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 108010051081 dopachrome isomerase Proteins 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- ZYBWTEQKHIADDQ-UHFFFAOYSA-N ethanol;methanol Chemical compound OC.CCO ZYBWTEQKHIADDQ-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229960002163 hydrogen peroxide Drugs 0.000 description 1
- FAHBNUUHRFUEAI-UHFFFAOYSA-M hydroxidooxidoaluminium Chemical compound O[Al]=O FAHBNUUHRFUEAI-UHFFFAOYSA-M 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 108010009400 levodopa receptor Proteins 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229940097156 peroxyl Drugs 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003244 pro-oxidative effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000021108 sauerkraut Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
本發明係關於一種用於修護皮膚的萃取物及含有此萃取物之組成物,其萃取物為一乳酸菌發酵物中分離所得之萃取物,具體而言,係關於一種植物乳酸桿菌(Lactobacillus plantarum,BCRC Number 10069)發酵物中分離所得之萃取物,以及包含此萃取物的皮膚修護用組成物。 The present invention relates to an extract for repairing the skin and a composition containing the extract. The extract is an extract obtained from a fermented lactic acid bacteria. Specifically, it relates to a Lactobacillus plantarum , BCRC Number 10069) The extract obtained from the fermented product, and the skin repairing composition containing the extract.
人體皮膚可保護身體免於受到各種氧化物質、重金屬、紫外線(UV)及空氣汙染等傷害,且能防止病毒、真菌及細菌等入侵身體,並且作為防止水分流失之保護屏障。 Human skin can protect the body from various oxidative substances, heavy metals, ultraviolet rays (UV) and air pollution, and it can prevent viruses, fungi and bacteria from invading the body and act as a protective barrier against water loss.
皮膚之結構大致分為三層,表皮、真皮和皮下脂肪,其中真皮層包含90%的皮膚,其由膠原蛋白、彈性蛋白、糖蛋白和透明質酸所組成。膠原蛋白係皮膚之主要成分,為一種重要的纖維蛋白,約佔人體蛋白質總量之25%(以重量計)。膠原蛋白構成大部分結締組織,並扮演如細胞間基質功能、結構支持功能、誘導細胞分裂和分化功能、提供皮膚拉伸強度功能等重要角色。已知紫外線及活性氧等會造成膠原蛋白產量降低並損害其結構,因此其與皮膚老化、黑色素沉澱造成皮膚色澤暗沉形成密切相關。 The structure of the skin is roughly divided into three layers, the epidermis, the dermis and the subcutaneous fat. The dermis contains 90% of the skin, which is composed of collagen, elastin, glycoprotein and hyaluronic acid. Collagen is the main component of the skin and is an important fibrin, accounting for about 25% of the total body protein (by weight). Collagen constitutes most of the connective tissue, and plays important roles such as intercellular matrix function, structural support function, inducing cell division and differentiation function, and providing skin tensile strength function. It is known that ultraviolet rays and active oxygen will reduce the production of collagen and damage its structure. Therefore, it is closely related to the formation of skin aging and melanin precipitation.
近年來,惡化的環境因素(例如過量紫外線、工廠或汽車所排廢的污染氣體等)導致皮膚屏障的損壞,持續地促使皮膚老化及色澤暗沉。因此,必須開發一種成本效益高之材料,此材料需可防止皮膚老化及黑色素沉澱且沒有副作用,並可製成方便以各種不同形式使用之組成物。 In recent years, deteriorating environmental factors (such as excessive ultraviolet rays, pollutant gases discharged from factories or cars, etc.) have caused damage to the skin barrier, which has continued to promote skin aging and dullness. Therefore, it is necessary to develop a cost-effective material that can prevent skin aging and melanin precipitation without side effects, and can be made into a composition that is convenient to use in various forms.
乳酸菌係藉由碳水化合物或纖維的發酵來產生乳酸,且其在人體中為具有益作用之細菌。截至目前為止,已發現約400種乳酸菌,並已將約18種品種開發成商業產品。 Lactic acid bacteria produce lactic acid through the fermentation of carbohydrates or fiber, and they are bacteria with beneficial effects in the human body. Up to now, about 400 species of lactic acid bacteria have been discovered, and about 18 species have been developed into commercial products.
乳酸菌進入人體腸道中,其經由自身的代謝活性分泌特定的材料,由於該等材料對人體有益,因此已經對乳酸菌進行了許多研究。乳酸菌在抗菌、抗氧化及免疫活性的效果已被報導,近年來,研究集中於乳酸菌的美白和保濕效果,且用作化妝品組成物、保養品組成物或防曬組成物的可能性大幅增加。 Lactic acid bacteria enter the human intestines and secrete specific materials through their own metabolic activity. Since these materials are beneficial to the human body, many studies have been conducted on lactic acid bacteria. The effects of lactic acid bacteria in antibacterial, antioxidant, and immune activities have been reported. In recent years, research has focused on the whitening and moisturizing effects of lactic acid bacteria, and the possibility of being used as a cosmetic composition, a skin care composition or a sunscreen composition has greatly increased.
在乳酸菌之中,已對乳酸桿菌的效果進行了許多研究,且針對免疫力、抗菌效果、皮膚美白的增強以及皮膚炎的改善等已被報導。其中,植物來源的乳酸菌(POLAB)係由植物原料的發酵食品(例如醬菜、醃菜或泡菜等)中分離的乳酸菌,其與乳品來源的乳酸菌有所區別。 Among the lactic acid bacteria, many studies have been conducted on the effects of lactic acid bacteria, and have been reported for immunity, antibacterial effect, enhancement of skin whitening, and improvement of dermatitis. Among them, plant-derived lactic acid bacteria (POLAB) are lactic acid bacteria isolated from fermented foods of plant raw materials (such as pickles, pickles, or kimchi), which are different from dairy-derived lactic acid bacteria.
與動物性乳酸菌相較之下,植物來源的乳酸菌不僅包含至少10倍以上的類型,且其對外部環境具有極佳的適應性。特別是從泡菜分離的植物性乳酸菌,其具有高含量的鹽、低pH值和高含量的天然抗菌材料,其可在極端環境下生長,因此植物來源的乳酸菌具有多種不同生理活性材料的優異生產力。 Compared with animal lactic acid bacteria, plant-derived lactic acid bacteria not only contain at least 10 times more types, but also have excellent adaptability to the external environment. Especially plant-derived lactic acid bacteria isolated from kimchi have high content of salt, low pH and high content of natural antibacterial materials, which can grow in extreme environments, so plant-derived lactic acid bacteria have excellent productivity of a variety of different physiologically active materials .
代表性的生理活性材料包括抗菌肽、免疫刺激劑及γ-胺基丁酸(GABA),其表現包括消炎和免疫抑制效果等各種生理功能。此外,乳酸菌是熱 穩定肽,且產生作為抗菌劑的細菌素,細菌素係由各種微生物產生之天然抗微生物蛋白質或蛋白質材料,通常指稱具有針對細菌菌株滅菌機制的材料,該細菌菌株在形態學和譜系學上類似於產生細菌素的微生物。因此,正在積極地開發使用含有這些材料的乳酸菌培養物萃取物或經乳酸菌發酵的植物萃取物的化妝品組成物、保養品組成物或防曬組成物之材料,且可符合近期偏愛環保和安全材料的趨勢。 Representative physiologically active materials include antibacterial peptides, immunostimulants, and γ-aminobutyric acid (GABA), and their performance includes various physiological functions such as anti-inflammatory and immunosuppressive effects. In addition, lactic acid bacteria are hot Stabilize peptides and produce bacteriocins as antibacterial agents. Bacteriocins are natural antimicrobial proteins or protein materials produced by various microorganisms. They usually refer to materials with sterilization mechanisms against bacterial strains, which are similar in morphology and genealogy For microorganisms that produce bacteriocins. Therefore, we are actively developing materials for cosmetic compositions, skin care products, or sunscreen compositions that use lactic acid bacteria culture extracts or lactic acid bacteria fermented plant extracts containing these materials, and can meet recent preferences for environmentally friendly and safe materials. trend.
目前,消費者不僅期望化妝品組成物、保養品組成物或防曬組成物中的一般照護效果,還需要其各種不同功能,例如,抗老化、改良細紋、抗刺激、消炎及美白效果等。近年來,基於上述目的,已經將各種植物萃取物用於化妝品中,並對以新概念為基礎之產品的期望越來越高,該新概念係藉由組合各種特性,顯示出改良的性能特徵範圍。 At present, consumers not only expect general care effects in cosmetic compositions, skin care products or sunscreen compositions, but also various functions, such as anti-aging, improving fine lines, anti-irritation, anti-inflammatory and whitening effects. In recent years, based on the above-mentioned purposes, various plant extracts have been used in cosmetics, and expectations for products based on new concepts have increased. The new concepts show improved performance characteristics by combining various characteristics. Scope.
為符合環保的時代,本發明的發明人已經努力研究乳酸菌培養物之萃取物的化妝品、保養品或防曬品之效果,其對皮膚是安全而沒有任何副作用的,並且有效地使用於預防老化及改善皮膚暗沉。 In order to comply with the era of environmental protection, the inventor of the present invention has worked hard to study the effects of lactic acid bacteria culture extracts in cosmetics, skin care products or sunscreens, which are safe for the skin without any side effects, and are effectively used to prevent aging and Improve dull skin.
此外,還要研究其在國內工業化中發展的可能性,發明人已經證實植物乳酸桿菌(Lactobacillus plantarum,BCRC Number 10069)發酵物之萃取物具有預防老化及改善皮膚暗沉的活性,從而完成本發明的內容。 In addition, it is necessary to study the possibility of its development in domestic industrialization. The inventor has confirmed that the extract of the fermentation product of Lactobacillus plantarum (BCRC Number 10069) has the activity of preventing aging and improving skin dullness, thus completing the present invention Content.
本發明的目的係提供一種用於修護皮膚的萃取物以及含此萃取物之組成物,該萃取物係由植物乳酸菌培養物中萃取而得,其中,該細菌體經移除。 The object of the present invention is to provide an extract for repairing the skin and a composition containing the extract, the extract is extracted from the plant lactic acid bacteria culture, wherein the bacterial body is removed.
本發明的另一個目的係提供一種預防皮膚老化及皮膚黯沉的方法,包括給個體施用用於修護皮膚的萃取物或含此萃取物之組成物,該萃取物係由植物乳酸菌發酵物中萃取而得,其中,該細菌體經移除。 Another object of the present invention is to provide a method for preventing skin aging and dull skin, including applying to an individual an extract for repairing the skin or a composition containing the extract, the extract is made from plant lactic acid bacteria fermentation It is obtained by extraction, in which the bacterial body is removed.
第1圖係為蕈菇酪胺酸酶活性試驗分析圖;第2圖係為細胞內黑色素含量試驗分析圖;第3圖係為細胞內酪胺酸酶活性試驗分析圖;第4圖係為使用西方墨點法進行蛋白質定量試驗分析圖;第5圖係為細胞存活率試驗分析圖;第6圖係為IBMX(c-AMP磷酸二酯酶抑制劑)試驗分析圖;第7圖係為SP600125(JNK抑制劑)試驗分析圖;第8圖係為PD98059(MEK1/2抑制劑)試驗分析圖;第9圖係為DPPH清除能力試驗分析圖;第10圖係為ABTS+自由基清除能力試驗分析圖;第11圖係為還原能力試驗分析圖;第12圖係為亞鐵離子螯合能力試驗分析圖;第13圖係為總酚含量試驗分析圖;第14圖係為纖維母細胞存活率試驗分析圖;第15圖係為纖維母細胞經H2O2處理後之存活率試驗分析圖。
The first picture is the analysis diagram of mushroom tyrosinase activity; the second picture is the analysis diagram of intracellular melanin content; the third picture is the analysis diagram of intracellular tyrosinase activity; the fourth picture is Use Western blot method for protein quantitative test analysis diagram; Figure 5 is the cell viability test analysis diagram; Figure 6 is the IBMX (c-AMP phosphodiesterase inhibitor) test analysis diagram; Figure 7 is the analysis diagram SP600125 (JNK inhibitor) test analysis diagram; the 8th picture is the PD98059 (MEK1/2 inhibitor) test analysis diagram; the 9th picture is the DPPH scavenging ability test analysis diagram; the 10th picture is the ABTS + free radical scavenging ability Test analysis chart; Picture 11 is the analysis chart of the reduction ability test;
為達到上述目的,本發明的一態樣係為提供一種用於修護皮膚的萃取物以及含此萃取物之組成物,該萃取物係由植物乳酸菌發酵物中萃取而得,其中,該細菌體經移除。 In order to achieve the above-mentioned objective, one aspect of the present invention is to provide an extract for repairing skin and a composition containing the extract. The extract is extracted from the fermented material of plant lactic acid bacteria, wherein Body is removed.
在本文中,術語「植物乳酸桿菌」係指一種乳酸桿菌屬之微生物,其為一種能夠產生乳酸之革蘭氏陰性細菌。該細菌係可在發酵食品如酸菜、醃菜及泡菜中發現。 In this article, the term "Lactobacillus plantarum" refers to a microorganism belonging to the genus Lactobacillus, which is a Gram-negative bacterium capable of producing lactic acid. The bacteria can be found in fermented foods such as sauerkraut, pickles and kimchi.
植物乳酸桿菌(Lactobacillus plantarum)菌株,其BCRC Number為10069,係採購自食品工業發展研究所菌種中心;而為驗證植物乳酸桿菌發酵物之萃取物的抗老化及美白效果,所使用之實驗細胞為B16F10小鼠皮膚黑色素瘤細胞(Mouse melanoma cells),其BCRC Number為60031,係採購自國家衛生研究院細胞庫。 Lactobacillus plantarum (Lactobacillus plantarum) strain, with a BCRC number of 10069, purchased from the Culture Center of the Food Industry Development Institute; and to verify the anti-aging and whitening effects of the extract of Lactobacillus plantarum fermentation, the experimental cells used B16F10 mouse skin melanoma cells (Mouse melanoma cells), with a BCRC Number of 60031, purchased from the National Institutes of Health Cell Bank.
在本文中,術語「發酵物」係指在含有培養基中培養微生物菌株時產生之副產物的培養基,其中,該菌株可以攝入和代謝培養基所含之營養物。術語「發酵物」包括所有使用培養基所形成的調配物(例如,培養基的稀釋劑或濃縮物、藉由乾燥培養基獲得的乾燥產物、培養基的粗製品或純化產物、其混合物等)。 As used herein, the term "fermented product" refers to a medium containing by-products produced when a microbial strain is cultivated in a medium, wherein the strain can ingest and metabolize the nutrients contained in the medium. The term "fermented product" includes all formulations formed by using a culture medium (for example, a diluent or concentrate of a culture medium, a dried product obtained by drying a culture medium, a crude product or a purified product of a culture medium, a mixture thereof, etc.).
具體而言,發酵物可為藉由培養植物乳酸桿菌菌株所獲得者,其中,該細菌體在培育後經移除。也就是說,其中細菌體經移除的經培養的培養基可以使用作為發酵物。 Specifically, the fermented product may be obtained by culturing a Lactobacillus plantarum strain, wherein the bacterial body is removed after the cultivation. That is, a cultured medium in which bacterial bodies are removed can be used as a fermented product.
更具體而言,用於修護皮膚的萃取物可由下述之方法獲得:(a)培養種菌;(b)製備發酵物;(c)除菌離心過濾;以及(d)除水。 More specifically, the extract used to repair the skin can be obtained by the following methods: (a) culturing seed bacteria; (b) preparing fermented product; (c) sterilizing centrifugal filtration; and (d) removing water.
在(a)及(b)步驟中,培養基可以是本領域中所使用的任何培養基,只要該培養基可以培育菌株,並在培育後回收發酵物即可,較佳為液體培養基,例如MRS培養基等;而培養種菌之溫度為35℃,培養箱之轉速為50~150rpm,較佳為80~120rpm,培養之時間為8~16小時,較佳為10~14小時;而製備發酵物之溫度、培養箱之轉速基本上與培養種菌相同,但發酵的時間為18~36小時,較佳為20~30小時。 In steps (a) and (b), the medium can be any medium used in the art, as long as the medium can grow strains, and the fermentation product can be recovered after cultivation, preferably a liquid medium, such as MRS medium, etc. ; And the temperature of the culture seed is 35℃, the speed of the incubator is 50~150rpm, preferably 80~120rpm, and the culture time is 8~16 hours, preferably 10~14 hours; and the temperature for preparing the fermented product, The rotation speed of the incubator is basically the same as that of the cultured bacteria, but the fermentation time is 18 to 36 hours, preferably 20 to 30 hours.
在步驟(c)中,係使用高速離心機進行離心,旋轉速率為1,300rpm至3,600rpm,較佳為2,600rpm至3,100rpm;離心15至40分鐘,較佳為20至35分鐘;離心後所獲取之上清液,係使用孔徑0.45μm過濾膜去除細菌體。 In step (c), a high-speed centrifuge is used for centrifugation, with a rotation rate of 1,300 rpm to 3,600 rpm, preferably 2,600 rpm to 3,100 rpm; centrifugation for 15 to 40 minutes, preferably 20 to 35 minutes; Obtain the supernatant, and use a 0.45 μm filter membrane to remove bacterial cells.
在步驟(d)中,係使用減壓濃縮機進行除水,或可使用其他用於除水之儀器皆可。 In step (d), a vacuum concentrator is used to remove water, or other equipment for removing water can be used.
本發明之用於修護皮膚的萃取物製備方法,其具體實施方式如下:(a)培養種菌:將植物乳酸桿菌置入50mL之MRS培養基中,於35℃、100rpm下培養12小時;(b)製備發酵物:取1mL步驟(a)所培養之植物乳酸桿菌的種菌,加入100mL之MRS培養基中,於35℃、100rpm下培養24小時,獲得植物乳酸桿菌發酵物;(c)除菌離心過濾:將植物乳酸桿菌發酵物在3000rpm、30min、25℃之條件下進行離心後取其上清液,再將上清液以孔徑0.45μm過濾膜去除植物乳酸桿菌之菌體,獲得植物乳酸桿菌之菌體經移除的上清液;(d)除水:將步驟(c)所獲得之上清液,將其水分完全抽除,獲得該萃取物。 The method for preparing the extract for repairing skin of the present invention has specific implementations as follows: (a) Cultivation of inoculum: Lactobacillus plantarum is placed in 50 mL of MRS medium and cultured at 35° C. and 100 rpm for 12 hours; (b) ) Preparation of fermented product: Take 1 mL of the Lactobacillus plantarum cultured in step (a), add it to 100 mL of MRS medium, and cultivate it at 35°C and 100 rpm for 24 hours to obtain the Lactobacillus plantarum fermented product; (c) Sterilizing centrifugation Filtration: Centrifuge the fermentation product of Lactobacillus plantarum under the conditions of 3000rpm, 30min and 25℃, and then take the supernatant liquid, and then remove the bacteria of Lactobacillus plantarum with a 0.45μm filter membrane to obtain Lactobacillus plantarum (D) Dewatering: the supernatant obtained in step (c) is completely removed from the water to obtain the extract.
在本文中,術語「老化」係指皮膚因來自內部基因遺傳及外部環境的傷害所造成之氧化現象;其中,內部基因遺傳所導致的氧化現象主要是由於活性氧(ROS,reactive oxygen species)作為細胞代謝的副產物的積累,ROS會對膜、酶和脫氧核糖核酸(DNA)等關鍵細胞成分造成損害。 In this article, the term "aging" refers to the oxidation phenomenon of the skin caused by internal genetic inheritance and damage from the external environment; among them, the oxidation phenomenon caused by internal genetic inheritance is mainly due to reactive oxygen species (ROS, reactive oxygen species). The accumulation of by-products of cell metabolism, ROS can cause damage to key cell components such as membranes, enzymes and deoxyribonucleic acid (DNA).
此外,外部環境的傷害所造成之氧化現象,例如紫外線,在過量紫外線的照射下,將導致細胞DNA改變,對皮膚造成累積性損傷;或者照射過量紫外線將造成黑色素沉澱,導致膚色黯沉,或更進一步演變為黑色素瘤(Melanoma)。 In addition, oxidation caused by damage to the external environment, such as ultraviolet light, will cause cell DNA changes under excessive ultraviolet radiation, causing cumulative damage to the skin; or excessive ultraviolet radiation will cause melanin precipitation, resulting in dull skin, or Further evolved into melanoma (Melanoma).
在本發明中,含有上述修護皮膚之萃取物的組成物可為化妝品、保養品、防曬品等皮膚外用產品,該等皮膚外用產品可調配為下述形式:溶液、外用軟膏、乳膏、泡沫、營養護膚霜、柔軟護膚霜、敷料、軟水、乳液、打底霜、香精、肥皂、液體清潔劑、沐浴劑、防曬霜、防曬油、懸浮液、乳化物、糊、凝膠、洗劑、粉末、肥皂、含界面活性劑的清潔劑、油、粉狀粉底、乳化粉底、蠟狀粉底、貼片及噴霧,但不以上述為限。 In the present invention, the composition containing the above-mentioned skin-repairing extract can be cosmetics, skin care products, sunscreens and other skin external products, and these skin external products can be formulated into the following forms: solution, external ointment, cream, Foam, nutritious skin cream, soft skin cream, dressing, soft water, lotion, base cream, essence, soap, liquid detergent, bath lotion, sunscreen, sunscreen oil, suspension, emulsion, paste, gel, lotion , Powders, soaps, detergents containing surfactants, oils, powdered foundations, emulsified foundations, waxy foundations, patches and sprays, but not limited to the above.
在本發明中,含有上述修護皮膚之萃取物的組成物可進一步含有至少一種化妝品、保養品或防曬品可接受的載劑,該載劑可為一般之常規組分,例如界面活性劑、保濕劑、低級醇、增稠劑、螯合劑、色素、防腐劑、香料及其組合等,但該組分不以上述為限。此外,該載劑可依據該等皮膚外用產品之形式進行適當比例之調整。 In the present invention, the composition containing the above-mentioned skin-repairing extract may further contain at least one acceptable carrier for cosmetics, skin care products or sunscreens, and the carrier may be a general conventional component, such as a surfactant, Humectants, lower alcohols, thickeners, chelating agents, pigments, preservatives, fragrances and combinations thereof, etc., but the components are not limited to the above. In addition, the carrier can be adjusted in an appropriate proportion according to the form of the external skin products.
當本發明之含有上述修護皮膚之萃取物的組成物為軟膏、糊、乳膏或凝膠時,作為載劑組分可以使用動物油、植物油、蠟、石蠟、澱粉、紫雲 英樹膠、纖維素衍生物、聚乙二醇、矽氧樹指、皂土、二氧化矽、滑石及氧化鋅等,但不以上述為限。該載劑組分可以單獨或以兩種或更多種組合使用。 When the composition of the present invention containing the above-mentioned skin repair extract is an ointment, paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, purple cloud can be used as the carrier component English gum, cellulose derivatives, polyethylene glycol, silica resin, bentonite, silica, talc, zinc oxide, etc., but not limited to the above. The carrier component may be used alone or in combination of two or more.
當本發明之含有上述修護皮膚之萃取物的組成物為粉末或噴霧時,作為載劑組分可以使用乳糖、滑石、二氧化矽、氫氧化鋁、矽酸鈣及聚醯胺粉末等;特別在噴霧的情況,調配物可以進一步含有推進劑,例如氯氟烴、丙烷/丁烷和二甲醚,但不以上述為限。該載劑組分可以單獨或以兩種或更多種的組合使用。 When the composition of the present invention containing the above-mentioned skin repair extract is powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate, polyamide powder, etc. can be used as carrier components; Especially in the case of spraying, the formulation may further contain propellants, such as chlorofluorocarbons, propane/butane and dimethyl ether, but not limited to the above. The carrier component may be used alone or in a combination of two or more.
當本發明之含有上述修護皮膚之萃取物的組成物為溶液或乳化物時,作為載劑組分可以使用溶劑、助溶劑或乳化劑(例如,水、乙醇、丙二醇、1,3-丁二醇及丙三醇等),較佳為棉籽油、花生油、玉米籽油、橄欖油、蓖麻油及芝麻油、甘油脂肪族酯、及聚乙二醇或去水山梨醇脂肪酸酯,但不以上述為限。該載劑組分可以單獨或以兩種或更多種的組合使用。 When the composition of the present invention containing the above-mentioned skin repair extract is a solution or an emulsion, a solvent, cosolvent or emulsifier (for example, water, ethanol, propylene glycol, 1,3-butane) can be used as a carrier component. Glycol and glycerol, etc.), preferably cottonseed oil, peanut oil, corn seed oil, olive oil, castor oil and sesame oil, glycerol fatty ester, and polyethylene glycol or sorbitan fatty acid ester, but not Limited to the above. The carrier component may be used alone or in a combination of two or more.
當本發明之含有上述修護皮膚之萃取物的組成物為懸浮液時,作為載劑組分可以使用液體稀釋劑(例如,水、乙醇或丙二醇)、懸浮劑(例如,乙氧化異硬脂醇、山梨糖醇聚氧乙烯酯和脫水山梨糖醇聚氧乙烯酯)、微晶型纖維素、羥基氧化鋁、皂土、瓊脂及紫雲英樹膠等,但不以上述為限。該載劑組分可以單獨或以兩種或更多種的組合使用。 When the composition of the present invention containing the above-mentioned skin repair extract is a suspension, a liquid diluent (for example, water, ethanol or propylene glycol), a suspending agent (for example, ethoxylated isostearyl) can be used as a carrier component. Alcohol, polyoxyethylene sorbitol and polyoxyethylene sorbitan), microcrystalline cellulose, aluminum oxyhydroxide, bentonite, agar, and milk vetch gum, etc., but not limited to the above. The carrier component may be used alone or in a combination of two or more.
當本發明之含有上述修護皮膚之萃取物的組成物為肥皂時,作為載劑組分可以使用脂肪酸的鹼金屬鹽、脂肪酸的半酯鹽、脂肪酸蛋白質水解物、羥乙基磺酸、羊毛酯衍生物、脂肪族醇、植物油、甘油及醣類等,但不以上述為限。該載劑組分可以單獨或以兩種或更多種的組合使用。 When the composition of the present invention containing the above-mentioned skin repairing extract is soap, the alkali metal salt of fatty acid, the half ester salt of fatty acid, fatty acid protein hydrolysate, isethion acid, wool can be used as the carrier component. Ester derivatives, aliphatic alcohols, vegetable oils, glycerin and sugars, etc., but not limited to the above. The carrier component may be used alone or in a combination of two or more.
後文中,將參考下述實施例更詳細揭示本發明內容。惟,對本發明所屬技術領域者,此等實施例係僅用於例示性說明之目的,且本發明不欲為此等實施例所限。 Hereinafter, the content of the present invention will be disclosed in more detail with reference to the following examples. However, for those skilled in the art to which the present invention belongs, these embodiments are only for illustrative purposes, and the present invention is not intended to be limited to these embodiments.
美白能力測定 Whitening ability test
實施例1:蕈菇酪胺酸酶活性分析 Example 1: Analysis of mushroom tyrosinase activity
使用蕈菇類的酪胺酸酶(Mushroom Tyrosinase)來進行初次篩選。左旋多巴(L-dopa)作為受質,其催化酪胺酸酶與左旋多巴受質作用反應後的產物降低時,可略先判定實驗之植物乳酸桿菌發酵物的萃取物樣品也許有抑制該催化作用的效果,具有美白功效之可能性。 Mushroom Tyrosinase (Mushroom Tyrosinase) was used for the initial screening. Levodopa (L-dopa) is used as a substrate, and when the product after the reaction of tyrosinase and levodopa substrate is reduced, it can be slightly judged that the extract sample of the fermentation product of Lactobacillus plantarum may be inhibited. The catalytic effect has the possibility of whitening effect.
當角質細胞受到陽光照射,便會活化黑色素細胞中酪胺酸酶的活性,進而啟動一連串化學反應,最後產生黑色素(Melanin)。此時含有大量黑色素的黑色素體便釋放到角質細胞中,使皮膚變黑。因此抑制酪胺酸酶活性被視為減少黑色素產生(美白)的關鍵步驟。 When keratinocytes are exposed to sunlight, it activates the activity of tyrosinase in melanocytes, which initiates a series of chemical reactions and finally produces melanin. At this time, the melanosomes containing a large amount of melanin are released into the keratinocytes, making the skin dark. Therefore, inhibition of tyrosinase activity is regarded as a key step in reducing melanin production (whitening).
酪胺酸酶抑制率公式(%)=(B-A)/B×100% Tyrosinase inhibition rate formula (%)=(B-A)/B×100%
酪胺酸酶相對活性公式(%)=A/B×100% Tyrosinase relative activity formula (%)=A/B×100%
A:樣品組於OD490之吸光值B:控制組於OD490之吸光值 A: The absorbance of the sample group at OD490 B: The absorbance of the control group at OD490
其中,OD490係指在波長490nm下的吸光值,可藉由分光光度計測得,其吸光值係指藉由測定被測物質在特定波長處或一定波長範圍內光的吸收度,對該物質進行定性和定量分析。 Among them, OD490 refers to the absorbance value at a wavelength of 490nm, which can be measured by a spectrophotometer. Qualitative and quantitative analysis.
參照第1圖,控制組為未加任何酪胺酸酶抑制物下經公式計算所得之抑制率,接著添加濃度1.32mg/mL、6.6mg/mL及13.2mg/mL之植物乳酸桿 菌發酵物的萃取物反應24小時後之抑制率,以及添加麴酸(kojic acid)、熊果素(arbutin)後之抑制率。 Refer to Figure 1, the control group is the inhibition rate calculated by the formula without adding any tyrosinase inhibitor, and then adding the plant lactic acid rods with the concentration of 1.32mg/mL, 6.6mg/mL and 13.2mg/mL The inhibition rate of the extract of the fermentation product after 24 hours of reaction, and the inhibition rate after adding kojic acid and arbutin.
由第1圖中可看出,當添加植物乳酸桿菌發酵物的萃取物後確實有抑制效果,當濃度提高至13.2mg/mL時,抑制率可達40%;雖植物乳酸桿菌發酵物的萃取物相對於麴酸、熊果素需較高濃度才可達到較高抑制率,但使用高濃度植物乳酸桿菌發酵物的萃取物對人體皮膚產生之副作用相較麴酸、熊果素輕微許多。 It can be seen from Figure 1 that when the extract of the fermentation product of Lactobacillus plantarum is added, there is indeed an inhibitory effect. When the concentration is increased to 13.2mg/mL, the inhibition rate can reach 40%; although the extraction of the fermentation product of Lactobacillus plantarum Compared with kojic acid and arbutin, a higher concentration is required to achieve a higher inhibition rate. However, the use of high-concentration extracts of Lactobacillus plantarum fermented products has much milder side effects on human skin than kojic acid and arbutin.
實施例2:細胞內黑色素含量分析 Example 2: Analysis of intracellular melanin content
利用氫氧化鈉之強鹼特性和高溫下將細胞內之黑色素溶出,並測定其OD405之吸光值,以此分析各種不同條件的處理對B16F10小鼠皮膚黑色素瘤細胞中黑色素含量的影響。 Utilizing the strong alkali properties of sodium hydroxide and high temperature to dissolve the melanin in the cells, and measuring the absorbance value of its OD405, in order to analyze the effect of various treatments on the melanin content in B16F10 mouse skin melanoma cells.
黑色素相對含量公式(%)=A/B×100% Formula of relative melanin content (%)=A/B×100%
A:樣品組於OD405之吸光值B:控制組於OD405之吸光值 A: The absorbance of the sample group at OD405 B: The absorbance of the control group at OD405
參照第2圖,控制組為未加任何酪胺酸酶抑制物下經公式計算所得之黑色素含量,接著添加濃度1.32mg/mL、6.6mg/mL及13.2mg/mL之植物乳酸桿菌發酵物的萃取物反應24小時後之黑色素含量,以及添加麴酸(kojic acid)、熊果素(arbutin)後之黑色素含量。 Referring to Figure 2, the control group is the melanin content calculated by the formula without adding any tyrosinase inhibitor, and then adding the fermented product of Lactobacillus plantarum at the concentration of 1.32mg/mL, 6.6mg/mL and 13.2mg/mL The melanin content of the extract after 24 hours of reaction, and the melanin content after adding kojic acid and arbutin.
由第2圖中可看出,當添加植物乳酸桿菌發酵物的萃取物後黑色素含量確實下降,當濃度提高至13.2mg/mL時,黑色素含量下降可達40%;雖植物乳酸桿菌發酵物的萃取物相對於麴酸、熊果素需較高濃度才可達到較高之黑色素下降量,但同前文所述,使用高濃度植物乳酸桿菌發酵物的萃取物對人體皮膚產生之副作用相較麴酸、熊果素輕微許多。 It can be seen from Figure 2 that when the extract of Lactobacillus plantarum fermented product is added, the melanin content does decrease. When the concentration is increased to 13.2mg/mL, the melanin content decreases up to 40%; although the content of Lactobacillus plantarum fermented Compared with kojic acid and arbutin, the extract requires a higher concentration to achieve a higher melanin reduction. However, as mentioned above, the use of high-concentration Lactobacillus plant fermented extract has side effects on human skin compared with kojic acid, Arbutin is much milder.
實施例3:細胞內酪胺酸酶活性分析 Example 3: Analysis of intracellular tyrosinase activity
使用冷凍解凍(Freeze-thaw cycle)的方法,將與植物乳酸桿菌發酵物的萃取物樣品反應後之B16F10小鼠皮膚黑色素瘤細胞置於-80℃低溫冷凍,並加入裂解溶液,使細胞內的水分形成冰霜,再將細胞取出置於室溫解凍,使冰霜還原成液狀。此過程會使細胞破裂,進而釋放出胞內物質,欲測定的酪胺酸酶即在其中。 Using the Freeze-thaw cycle method, the B16F10 mouse skin melanoma cells after the reaction with the extract sample of the fermentation product of Lactobacillus plantarum were frozen at a low temperature of -80°C, and the lysis solution was added to make the cells The moisture forms frost, and then the cells are taken out and thaw at room temperature to restore the frost to a liquid state. This process ruptures the cell and releases intracellular material, where the tyrosinase to be measured is in it.
藉由加入酪胺酸酶的催化左旋多巴受質(L-dopa)之反應,分析其產物多巴色素(dopachrome)的生成量,即可推知其酪胺酸酶的相對活性。 By adding tyrosinase to catalyze the reaction of levodopa receptor (L-dopa), and analyzing the production of dopachrome, the relative activity of its tyrosinase can be inferred.
酪胺酸酶的相對活性公式(%)=A/B×100% The relative activity formula of tyrosinase (%)=A/B×100%
A:樣品組於OD490之吸光值B:控制組於OD490之吸光值 A: The absorbance of the sample group at OD490 B: The absorbance of the control group at OD490
參照第3圖,控制組為未加任何酪胺酸酶抑制物下經公式計算所得之酪胺酸酶活性,接著添加濃度1.32mg/mL、6.6mg/mL及13.2mg/mL之植物乳酸桿菌發酵物的萃取物反應24小時後之酪胺酸酶活性,以及添加麴酸(kojic acid)、熊果素(arbutin)後之酪胺酸酶活性。 Refer to Figure 3, the control group is the tyrosinase activity calculated by the formula without adding any tyrosinase inhibitor, and then adding the concentration of 1.32mg/mL, 6.6mg/mL and 13.2mg/mL of Lactobacillus plantarum The tyrosinase activity of the extract of the fermented product after 24 hours of reaction, and the tyrosinase activity after adding kojic acid and arbutin.
由第3圖中可看出,當添加植物乳酸桿菌發酵物的萃取物後酪胺酸酶活性確實下降,當濃度提高至13.2mg/mL時,酪胺酸酶活性下降可達80%;雖植物乳酸桿菌發酵物的萃取物相對於麴酸、熊果素需較高濃度才可達到較高之酪胺酸酶活性下降量,但同前文所述,使用高濃度植物乳酸桿菌發酵物的萃取物對人體皮膚產生之副作用相較麴酸、熊果素輕微許多。 It can be seen from Figure 3 that when the extract of the fermentation product of Lactobacillus plantarum is added, the tyrosinase activity does decrease. When the concentration is increased to 13.2 mg/mL, the tyrosinase activity decreases by up to 80%; The extract of the fermentation product of Lactobacillus plantarum requires a higher concentration than kojic acid and arbutin to achieve a higher decrease in tyrosinase activity. The side effects of human skin are much milder than those of kojic acid and arbutin.
實施例4:蛋白質定量試驗分析 Example 4: Protein quantitative test analysis
與黑色素合成相關的之蛋白質,諸如第一型黑色素皮質素受體(melanocortin 1 receptor,MC1R)、小眼相關轉錄因子(microphthalmia transcription
factor,MITF)、酪氨酸酶相關蛋白1(tyrosinase-related protein 1,TRP-1)、酪氨酸酶相關蛋白2(tyrosinase-related protein 1,TRP-2)及酪氨酸酶(tyrosinase)等;另一方面,p38蛋白、環磷腺苷效應元件結合蛋白(cAMP-response element binding protein,CREB)經磷酸化後,會促使小眼相關轉錄因子(MITF)表達而促進黑色素生成;c-Jun胺基末端激酶(c-Jun N-terminal kinase,JNK)及細胞外信號調節激酶(extracellular signal-regulated kinase,ERK)經磷酸化後,則會促使MITF降解而抑制黑色素生成。
Proteins related to melanin synthesis, such as the first type melanocortin receptor (MC1R), microphthalmia transcription factor (microphthalmia transcription factor)
factor, MITF), tyrosinase-related protein 1 (tyrosinase-related
蛋白質定量試驗分析係將蛋白質濃度以BCA方法(bicinchoninic acid assay)將該蛋白質萃取液進行定量。以牛血清白蛋白(Bovine serum albumin;BSA)製作標準曲線,並吸取25μL之BSA與含二甲基亞碸(DMSO)溶劑混合之不同濃度樣品的蛋白質萃取液至微量離心管,加入200μL Pierce® BCA Protein Assay Kit(A:B=50:1),均勻混合,放置於37℃反應30分鐘。30分鐘後吸取70μL至96孔盤,後續針對各混合樣品進行西方墨點分析法(western blotting assay)。 The protein quantification test analysis system quantifies the protein concentration of the protein extract by the BCA method (bicinchoninic acid assay). Prepare a standard curve with Bovine serum albumin (BSA), and pipette 25μL of BSA and the protein extract of different concentrations of samples containing dimethylsulfoxide (DMSO) solvent into a microcentrifuge tube, and add 200μL Pierce ® BCA Protein Assay Kit (A:B=50:1), mix evenly, and place it at 37°C for 30 minutes. After 30 minutes, 70 μL was pipetted to a 96-well plate, and then western blotting assay was performed on each mixed sample.
在該蛋白質定量試驗分析中,藉由添加α-黑色素細胞刺激素(α-melanocyte-stimulating hormone,α-MSH),濃度0.264mg/mL、1.32mg/mL、6.6mg/mL、13.2mg/mL及19.8mg/mL之植物乳酸桿菌發酵物的萃取物,以及添加熊果素(arbutin)至該等與黑色素合成相關之蛋白質中,觀察該等與黑色素合成相關之蛋白質表現量。此外,因甘油醛-3-磷酸脫氫酶(glyceraldehyde-3-phosphate dehydrogenase,GAPDH)會因黑色素影響而使其表現失調,故以其訊號強度作為參考基準,與該等黑色素合成相關之蛋白質在添加植物乳酸桿菌發酵物的萃取物後之表現量作為比較。 In the protein quantitative test analysis, by adding α-melanocyte-stimulating hormone (α-MSH), the concentration is 0.264mg/mL, 1.32mg/mL, 6.6mg/mL, 13.2mg/mL And 19.8mg/mL of the extract of the fermentation product of Lactobacillus plantarum, and adding arbutin to the proteins related to melanin synthesis, and observe the protein expression related to melanin synthesis. In addition, because glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is affected by melanin and its performance is imbalanced, its signal strength is used as a reference standard, and the proteins related to the synthesis of melanin are The expression level after adding the extract of the fermentation product of Lactobacillus plantarum was used as a comparison.
參照第4圖,圖中分別展示西方墨點分析法之結果圖,以及該等與黑色素合成相關蛋白質以GAPDH作為參考基準之比較圖表,為使圖式簡潔,圖中均以英文縮寫表示;由第4圖中可看出,隨著植物乳酸桿菌發酵物的萃取物之濃度提高,該等與黑色素合成相關蛋白質之表現量明顯下降,且針對如酪胺酸酶、TRP-1、TRP-2之效果特別顯著,具體數據如表1所示,為使表格簡潔,表中均以英文縮寫表示。 Refer to Figure 4, which shows the results of the Western blot analysis method and the comparison chart of the proteins related to melanin synthesis using GAPDH as the reference standard. In order to keep the diagram concise, the diagrams are all represented by English abbreviations; by As can be seen in Figure 4, as the concentration of the extract of the fermentation product of Lactobacillus plantarum increases, the expression level of these proteins related to melanin synthesis decreases significantly, and targets such as tyrosinase, TRP-1, and TRP-2. The effect is particularly significant. The specific data is shown in Table 1. In order to keep the table concise, the English abbreviations are used in the table.
實施例5:細胞存活率分析 Example 5: Analysis of cell viability
細胞存活率分析係藉由B16F10小鼠皮膚黑色素瘤細胞內粒線體的琥珀胺酸脫氫酶(succinate dehydrogenase)能MTT([3-(4,5)-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)淡黃色水溶液之四唑環切斷,產生藍紫色之甲(formazan)結晶而分辨細胞是否存活,由於死亡細胞之粒線體中不具有活性之脫氫酶,所以MTT的顏色仍然為黃色不會產生藍紫色之甲結晶。而甲結晶於波長570nm時具有最大吸光值,因此可經由吸光值的測定來計算細胞的存活率。 Cell viability analysis is based on the ability of succinate dehydrogenase in the mitochondria of B16F10 mouse skin melanoma cells to MTT([3-(4,5)-dimethylthiazol-2-yl)-2, The tetrazolium ring of 5-diphenyltetrazolium bromide) in the pale yellow aqueous solution is cut to produce a blue-violet nail (formazan) crystallizes to distinguish whether the cells are alive or not. Since there is no active dehydrogenase in the mitochondria of dead cells, the color of MTT is still yellow and does not produce blue-violet nails. crystallization. And A The crystal has the maximum absorbance at a wavelength of 570nm, so the survival rate of the cells can be calculated by measuring the absorbance.
細胞存活率公式(%)=A/B×100% Cell survival rate formula (%)=A/B×100%
A:樣品組於OD570之吸光值B:控制組於OD570之吸光值 A: The absorbance value of the sample group at OD570 B: The absorbance value of the control group at OD570
參照第5圖,控制組為未加任何植物乳酸桿菌發酵物的萃取物下經公式計算所得之細胞存活率,接著添加濃度1.32mg/mL、6.6mg/mL、13.2mg/mL、19.8mg/mL及26.4mg/mL之植物乳酸桿菌發酵物的萃取物反應24小時後之細胞存活率。 Refer to Figure 5, the control group is the cell survival rate calculated by the formula without adding any Lactobacillus plantarum fermentation extract, and then adding the concentration of 1.32mg/mL, 6.6mg/mL, 13.2mg/mL, 19.8mg/ The cell survival rate after 24 hours of reaction with the extract of the fermentation product of Lactobacillus plantarum at mL and 26.4 mg/mL.
由第5圖中可看出,當添加植物乳酸桿菌發酵物的萃取物後細胞之存活率依然沒有顯著變化,但當植物乳酸桿菌發酵物的萃取物之濃度提高至19.8mg/mL時,細胞之存活率開始降低;當濃度達到26.4mg/mL時,細胞之存活率僅剩40%,由此可知,使用植物乳酸桿菌發酵物的萃取物之最高濃度範圍約為13.2mg/mL,而最低有效之濃度範圍約為1.32mg/mL。 It can be seen from Figure 5 that the survival rate of the cells still does not change significantly after adding the extract of the fermentation product of Lactobacillus plantarum, but when the concentration of the extract of the fermentation product of Lactobacillus plantarum is increased to 19.8 mg/mL, the cell survival rate The survival rate began to decrease; when the concentration reached 26.4mg/mL, the survival rate of the cells was only 40%. It can be seen that the highest concentration range of the extract using Lactobacillus plantarum fermentation is about 13.2mg/mL, and the lowest The effective concentration range is about 1.32mg/mL.
實施例6:美白作用機制分析 Example 6: Analysis of whitening mechanism
藉由分別將IBMX(c-AMP磷酸二酯酶抑制劑)、SP600125(JNK抑制劑)、PD98059(MEK1/2抑制劑)以及植物乳酸桿菌發酵物的萃取物與細胞混合,該等抑制劑對可促進黑色素生成;另將上述各抑制劑分別與植物乳酸桿菌發酵物的萃取物混合後再與細胞混合作為對照,觀察植物乳酸桿菌發酵物的萃取物對於抑制黑色素生成之機制。 By mixing the extracts of IBMX (c-AMP phosphodiesterase inhibitor), SP600125 (JNK inhibitor), PD98059 (MEK1/2 inhibitor) and the fermentation product of Lactobacillus plantarum with cells separately, these inhibitors It can promote the production of melanin; in addition, the above-mentioned inhibitors were mixed with the extract of the fermentation product of Lactobacillus plantarum and then mixed with the cells as a control to observe the mechanism of the extract of the fermentation product of Lactobacillus plantarum on inhibiting melanin production.
首先,以細胞密度為5×104cells/well的B16F10小鼠皮膚黑色素瘤細胞混合含有100nM α-MSH的培養基種入24孔培養盤中,置入37℃、5% CO2培養箱24小時;接著換置含有不同類型之10μM抑制劑的培養基(控制組之培養基不含抑制劑),置於培養箱反應1小時;其後換置含有不同類型之10μM抑制劑及不同濃度之植物乳酸桿菌發酵物的萃取物,置於培養箱反應23小時;接著去除培養基,以PBS清洗二次,加入100μL 1N NaOH溶液(內含10% DMSO),於60℃ 反應1小時;最後取70μL至96well,使用免疫酵素分析儀(ELISA)測定OD405吸光值。 First, B16F10 mouse skin melanoma cells with a cell density of 5×10 4 cells/well were mixed with a medium containing 100nM α-MSH into a 24-well culture dish, and placed in a 37°C, 5% CO 2 incubator for 24 hours ; Then replaced with a medium containing different types of 10μM inhibitors (the control group did not contain inhibitors), placed in an incubator for 1 hour; then replaced with different types of 10μM inhibitors and different concentrations of Lactobacillus plantarum The extract of the fermented product was placed in an incubator for 23 hours; then the medium was removed, washed twice with PBS, 100μL of 1N NaOH solution (containing 10% DMSO) was added, and reacted at 60°C for 1 hour; finally 70μL to 96well, The OD405 absorbance value was measured using an immunoenzyme analyzer (ELISA).
參照第6圖、第7圖及第8圖,單獨添加IBMX、SP600125或PD98059時之吸光值相較於控制組並未出現任何明顯的變化,而單獨添加植物乳酸桿菌發酵物的萃取物後,吸光值出現明顯下降,表示對黑色素生成具有抑制效果;另分別將該等抑制劑分別與植物乳酸桿菌發酵物的萃取物混合之吸光值,則再度上升,代表植物乳酸桿菌之美白機制與IBMX、SP600125或PD98059等抑制劑對於黑色素生成機制相關。 Referring to Figure 6, Figure 7, and Figure 8, the absorbance value when IBMX, SP600125 or PD98059 was added alone did not show any significant changes compared to the control group, and the extract of the fermentation product of Lactobacillus plantarum was added separately. The light absorption value drops significantly, indicating that it has an inhibitory effect on melanin production. In addition, the light absorption value of these inhibitors separately mixed with the extract of the fermentation product of Lactobacillus plantarum rises again, which represents the whitening mechanism of Lactobacillus plantarum and IBMX, Inhibitors such as SP600125 or PD98059 are related to the mechanism of melanin production.
抗氧化能力測定 Determination of antioxidant capacity
實施例7:DPPH自由基清除能力試驗分析 Example 7: DPPH free radical scavenging ability test analysis
脂質在自行氧化的過程中會產生自由基而造成脂質酸敗,常見的抗氧化物藉由提供氫(Hydrogen doner)來清除脂質過氧化物自由基(Peroxyl free radical),進而達到抑制氧化鏈鎖反應之進行。 In the process of self-oxidation, lipids will generate free radicals and cause lipid rancidity. Common antioxidants provide hydrogen (Hydrogen doner) to scavenge lipid peroxide free radicals (Peroxyl free radicals), thereby inhibiting the oxidation chain reaction. It goes on.
DPPH(2,2-Diphenyl-1-picrylhydrazyl)為一種穩定的自由基,與乙醇(Methanol)溶液在517nm下有較強的吸光值,故若吸光值越低,表示抗氧化物的供氫能力愈強,抗氧化能力愈好。 DPPH (2,2-Diphenyl-1-picrylhydrazyl) is a stable free radical. It has a strong absorbance value at 517nm with ethanol (Methanol) solution, so if the absorbance value is lower, it indicates the antioxidant capacity of hydrogen supply The stronger, the better the antioxidant capacity.
DPPH自由基清除率(%)=(1-A/B)×100% DPPH free radical scavenging rate (%)=(1-A/B)×100%
A:樣品組於OD517之吸光值B:控制組於OD517之吸光值 A: The absorbance value of the sample group at OD517 B: The absorbance value of the control group at OD517
參照第9圖,空白試驗為未加任何抗氧化劑,接著添加濃度0.176mg/mL、0.88mg/mL、1.76mg/mL、4.4mg/mL及8.8mg/mL之植物乳酸桿菌發酵物的萃取物反應24小時後之DPPH清除能力,以及添加維生素C(Vit C)、丁基羥 基茴香醚(BHA)後之DPPH清除能力,為使圖式簡潔,圖中維生素及丁基羥基茴香醚均以英文縮寫表示。 Refer to Figure 9, the blank test is without any antioxidants, followed by the addition of extracts of the fermentation product of Lactobacillus plantarum at concentrations of 0.176mg/mL, 0.88mg/mL, 1.76mg/mL, 4.4mg/mL and 8.8mg/mL The DPPH scavenging ability after 24 hours of reaction, and the addition of vitamin C (Vit C) and butyl hydroxy The DPPH scavenging ability after BHA is shown in English abbreviations for vitamins and butylated hydroxyanisole in order to make the diagram concise.
由第9圖中可看出,當添加植物乳酸桿菌發酵物的萃取物後,DPPH清除能力確實上升,當濃度提高至8.8mg/mL時,DPPH清除能力可達約60%;雖植物乳酸桿菌發酵物的萃取物相對於維生素C、丁基羥基茴香醚需較高濃度才可達到較高之DPPH清除能力,但使用高濃度植物乳酸桿菌發酵物的萃取物對人體皮膚產生之副作用相較維生素C、丁基羥基茴香醚輕微許多。 It can be seen from Figure 9 that when the extract of Lactobacillus plantarum fermented product is added, the DPPH scavenging ability does increase. When the concentration is increased to 8.8mg/mL, the DPPH scavenging ability can reach about 60%; although Lactobacillus plantarum Compared with vitamin C and butylated hydroxyanisole, the fermented extract needs a higher concentration to achieve higher DPPH scavenging ability. However, the use of high-concentration Lactobacillus plantarum fermented extract has side effects on human skin compared with vitamins C. Butylated hydroxyanisole is much lighter.
實施例8:ABTS+自由基清除能力試驗分析 Example 8: ABTS + free radical scavenging ability test analysis
ABTS(2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid))是一種化學性自由基引發劑,同時在反應中也是顯色劑。ABTS經活性氧氧化後,可生成穩定的藍綠色陽離子ABTS+。當其加入具有抗氧化活性的物質後,可與ABTS+發生反應而使顏色變淡,因此當反應後的吸光值越低時,就表示樣品清除ABTS+自由基的能力越強。 ABTS (2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)) is a chemical free radical initiator and also a color developing agent in the reaction. After ABTS is oxidized by active oxygen, it can generate stable blue-green cation ABTS + . When it is added with a substance with antioxidant activity, it can react with ABTS + to make the color lighter. Therefore, the lower the absorbance value after the reaction, the stronger the ability of the sample to scavenge ABTS+ free radicals.
ABTS+自由基清除率(%)=(1-A-B)×100% ABTS + free radical scavenging rate (%)=(1-AB)×100%
A:樣品組於OD410之吸光值B:控制組於OD410之吸光值 A: The absorbance of the sample group at OD410 B: The absorbance of the control group at OD410
參照第10圖,空白試驗為未加任何抗氧化劑,接著添加濃度0.211mg/mL、1.056mg/mL、5.28mg/mL、10.56mg/mL及15.84mg/mL之植物乳酸桿菌發酵物的萃取物反應24小時後之DPPH清除能力,以及添加維生素C(VitC)、丁基羥基茴香醚(BHA)後之ABTS+清除能力,為使圖式簡潔,圖中維生素及丁基羥基茴香醚均以英文縮寫表示。 Refer to Figure 10, the blank test is that no antioxidant is added, and then the extract of the fermentation product of Lactobacillus plantarum at the concentration of 0.211mg/mL, 1.056mg/mL, 5.28mg/mL, 10.56mg/mL and 15.84mg/mL is added The DPPH scavenging ability after 24 hours of reaction, and the ABTS + scavenging ability after adding vitamin C (VitC) and butyl hydroxyanisole (BHA). To keep the diagram simple, the vitamins and butyl hydroxyanisole in the figure are all in English Abbreviation.
由第10圖中可看出,當添加植物乳酸桿菌發酵物的萃取物後,ABTS+清除能力確實上升,當濃度提高至5.28mg/mL時,DPPH清除能力可達約 100%;雖植物乳酸桿菌發酵物的萃取物相對於維生素C、丁基羥基茴香醚需較高濃度才可達到較高之ABTS+清除能力,但使用高濃度植物乳酸桿菌發酵物的萃取物對人體皮膚產生之副作用相較維生素C、丁基羥基茴香醚輕微許多。 It can be seen from Figure 10 that when the extract of Lactobacillus plantarum fermentation is added, the ABTS + scavenging ability does increase. When the concentration is increased to 5.28mg/mL, the DPPH scavenging ability can reach about 100%; although plant lactic acid Compared with vitamin C and butylated hydroxyanisole, the extract of Bacillus fermented product needs a higher concentration to achieve higher ABTS + removal ability. However, the use of high-concentration extract of Lactobacillus plantarum fermented product has side effects on human skin. It is much milder than vitamin C and butylated hydroxyanisole.
實施例9:還原能力試驗分析 Example 9: Analysis of reduction ability test
依據普魯士藍Fe4[Fe(CN)6]3的生成量為指標,原理為將赤血鹽K3Fe(CN)6還原成黃血鹽K4Fe(CN)6,然後黃血鹽再利用Fe3+形成普魯士藍,藉由波長700nm的吸光值變化來檢測還原力的大小,吸光值越高則表示還原力越強。 According to the production of Prussian blue Fe 4 [Fe(CN) 6 ] 3 as an indicator, the principle is to reduce red blood salt K 3 Fe(CN) 6 to yellow blood salt K 4 Fe(CN) 6 , and then yellow blood salt again Using Fe 3+ to form Prussian blue, the reducing power is detected by the change in absorbance at a wavelength of 700 nm. The higher the absorbance, the stronger the reducing power.
還原力(%)=(A/B)×100% Reducing power (%)=(A/B)×100%
A:樣品組於OD700之吸光值B:控制組於OD700之吸光值 A: The absorbance of the sample group at OD700 B: The absorbance of the control group at OD700
參照第11圖,空白試驗為未加任何抗氧化劑,接著添加濃度0.042mg/mL、0.211mg/mL、1.056mg/mL、2.112mg/mL及3.168mg/mL之植物乳酸桿菌發酵物的萃取物反應24小時後之還原能力,以及添加維生素C(Vit C)、丁基羥基茴香醚(BHA)後之還原能力,為使圖式簡潔,圖中維生素及丁基羥基茴香醚均以英文縮寫表示。 Refer to Figure 11, the blank test is that no antioxidant is added, and then the extract of the fermentation product of Lactobacillus plantarum at the concentration of 0.042mg/mL, 0.211mg/mL, 1.056mg/mL, 2.112mg/mL and 3.168mg/mL is added The reducing power after 24 hours of reaction, as well as the reducing power after adding vitamin C (Vit C) and butyl hydroxyanisole (BHA), in order to make the diagram concise, the vitamins and butyl hydroxyanisole in the figure are all expressed in English abbreviations .
由第11圖中可看出,當添加植物乳酸桿菌發酵物的萃取物後,還原能力確實上升,當濃度提高至3.168mg/mL時,還原能力可達約70%;雖植物乳酸桿菌發酵物的萃取物相對於維生素C、丁基羥基茴香醚需較高濃度才可達到較高之還原能力,但使用高濃度植物乳酸桿菌發酵物的萃取物對人體皮膚產生之副作用相較維生素C、丁基羥基茴香醚輕微許多。 It can be seen from Figure 11 that when the extract of the fermentation product of Lactobacillus plantarum is added, the reducing power does increase. When the concentration is increased to 3.168mg/mL, the reducing power can reach about 70%; although the fermentation product of Lactobacillus plantarum Compared with vitamin C and butylated hydroxyanisole, the extract of butyl hydroxyanisole requires a higher concentration to achieve higher reducing power. However, the use of a high concentration of Lactobacillus plantarum fermented extract has side effects on human skin compared to vitamin C and butyl Glyoxyanisole is slightly more.
實施例10:亞鐵離子螯合能力試驗分析 Example 10: Test analysis of ferrous ion chelating ability
在金屬離子中Fe2+是最具影響力的促氧化劑,利用Fe2+與菲洛嗪(ferrozine)之鮮紅色複合物在波長562nm有強吸光值的特性,可以測定樣品對 Fe2+的螯合能力。當樣品螯合Fe2+時,會造成OD562吸光值的降低,吸光值越低表示其螯合金屬離子的能力越強。乙二胺四乙酸(EDTA)則作為正向對照組。 Among the metal ions, Fe 2+ is the most influential pro-oxidant. The bright red complex of Fe 2+ and ferrozine has a strong absorbance at a wavelength of 562 nm, which can be used to determine the sample’s effect on Fe 2+ . Chelating ability. When the sample chelates Fe 2+ , it will cause a decrease in the OD562 absorbance value. The lower the absorbance value, the stronger its ability to chelate metal ions. Ethylenediaminetetraacetic acid (EDTA) was used as a positive control group.
亞鐵離子螯合能力(%)=(1-A/B)×100% Ferrous ion chelating capacity (%)=(1-A/B)×100%
A:樣品組於OD562之吸光值B:控制組於OD562之吸光值 A: The absorbance of the sample group at OD562 B: The absorbance of the control group at OD562
參照第12圖,空白試驗為未加任何螯合劑,接著添加濃度0.053mg/mL、0.106mg/mL、0.264mg/mL及0.528mg/mL之植物乳酸桿菌發酵物的萃取物反應24小時後之螯合能力,以及添加濃度0.02mg/mL、0.04mg/mL、0.08mg/mL之乙二胺四乙酸(EDTA)的螯合能力,為使圖式簡潔,圖中乙二胺四乙酸以英文縮寫表示。 Refer to Figure 12, the blank test is that no chelating agent is added, and then the extract of the fermentation product of Lactobacillus plantarum at the concentration of 0.053mg/mL, 0.106mg/mL, 0.264mg/mL and 0.528mg/mL is added after 24 hours of reaction. The chelating ability and the chelating ability of ethylenediaminetetraacetic acid (EDTA) added at concentrations of 0.02mg/mL, 0.04mg/mL, and 0.08mg/mL. In order to simplify the diagram, ethylenediaminetetraacetic acid is in English Abbreviation.
由第12圖中可看出,當添加植物乳酸桿菌發酵物的萃取物後,螯合能力確實上升,當濃度提高至0.528mg/mL時,螯合能力可達約90%;雖植物乳酸桿菌發酵物的萃取物相對於乙二胺四乙酸需較高濃度才可達到較高之螯合能力,但使用高濃度植物乳酸桿菌發酵物的萃取物對人體皮膚產生之副作用相較乙二胺四乙酸輕微許多。 It can be seen from Figure 12 that when the extract of the fermentation product of Lactobacillus plantarum is added, the chelating ability does increase. When the concentration is increased to 0.528mg/mL, the chelating ability can reach about 90%; although Lactobacillus plantarum Compared with ethylenediaminetetraacetic acid, the fermented extract needs a higher concentration to achieve higher chelating ability. However, the use of high-concentration Lactobacillus plantarum fermented extract has side effects on human skin compared with ethylenediaminetetraacetic acid. Acetic acid is much lighter.
實施例11:總酚含量試驗分析 Example 11: Test analysis of total phenol content
以酚類指示劑(Folin-Ciocalteu's phenol reagent)檢測樣品中酚類化合物的含量。樣品裡如果有酚類化合物,則會與酚類指示劑在波長750nm反應呈色,當吸光值越高,表示樣品中所含多酚類物質越多,抗氧化能力越強。配置不同已知濃度的沒食子酸與酚類指示劑反應作為標準品並製作檢量線,檢測未知物與指示劑反應後之吸收值,對應檢量線則可測得其酚類化合物的含量。 Folin-Ciocalteu's phenol reagent was used to detect the content of phenolic compounds in the samples. If there are phenolic compounds in the sample, they will react with the phenolic indicator at a wavelength of 750nm to form a color. The higher the absorbance value, the more polyphenols in the sample and the stronger the antioxidant capacity. Configure the reaction of different known concentrations of gallic acid and phenolic indicator as standard products and make a calibration curve to detect the absorption value of the unknown substance after the reaction with the indicator, and the corresponding calibration curve can measure the phenolic compound content.
參照第13圖,空白試驗為未加任何植物乳酸桿菌發酵物的萃取物,接著添加濃度0.66mg/mL、3.3mg/mL、16.5mg/mL、33mg/mL及49.5mg/mL 之植物乳酸桿菌發酵物的萃取物反應24小時後之總酚含量(以沒食子酸當量作為參考值)。 Refer to Figure 13, the blank test is the extract without any fermentation of Lactobacillus plantarum, and then add the concentration of 0.66mg/mL, 3.3mg/mL, 16.5mg/mL, 33mg/mL and 49.5mg/mL The total phenol content of the extract of the fermentation product of Lactobacillus plantarum after 24 hours of reaction (using gallic acid equivalent as a reference value).
由第13圖中可看出,當添加植物乳酸桿菌發酵物的萃取物後,總酚含量確實上升,當濃度提高至49.5mg/mL時,總酚含量相對於沒食子酸當量可達約1當量,即表示此濃度下之總酚含量與沒食子酸相近。 It can be seen from Figure 13 that when the extract of the fermentation product of Lactobacillus plantarum is added, the total phenol content does increase. When the concentration is increased to 49.5 mg/mL, the total phenol content relative to the gallic acid equivalent can reach approximately One equivalent means that the total phenol content at this concentration is similar to gallic acid.
實施例12:纖維母細胞存活率試驗分析 Example 12: Fibroblast survival rate test analysis
為確認植物乳酸桿菌發酵物的萃取物在不同濃度下對細胞所產生之毒性,使用纖維母細胞(WS1)進行試驗,以判斷植物乳酸桿菌發酵物的萃取物使用之適合濃度。 In order to confirm the toxicity of the extract of the fermentation product of Lactobacillus plantarum to the cells at different concentrations, a test was carried out using fibroblasts (WS1) to determine the appropriate concentration of the extract of the fermentation product of Lactobacillus plantarum.
首先以細胞密度為5×104cells/well的纖維母細胞植入24孔培養盤中,置入37℃、5%CO2培養箱培養24小時;其後去除培養基,分別依照不同濃度的植物乳酸桿菌發酵物的萃取物、特定濃度之過氧化氫(H2O2)及維生素E(Trolox),與DMEM培養基混合後更換24well內的培養基,置入培養箱培養24小時;接著去除培養基,以PBS洗滌二次,每孔加入500μL稀釋後的MTT溶液(1mg/mL),鋁箔紙包覆孔盤避光處理,置入培養箱反應30分鐘;最後去除培養基,以PBS洗滌二次,每孔加入500μL DMSO溶解藍紫色的甲(formazan)結晶物,最後使用免疫酵素分析儀(ELISA)測定產物之OD570吸光值。 Firstly, fibroblasts with a cell density of 5×10 4 cells/well were implanted in a 24-well culture dish, and placed in a 37°C, 5% CO 2 incubator for 24 hours; after that, the medium was removed, and the culture medium was removed according to different concentrations of plants. Lactobacillus fermented extract, hydrogen peroxide (H 2 O 2 ) and vitamin E (Trolox) of specific concentration, mixed with DMEM medium, replaced the medium in 24well, placed in an incubator for 24 hours; then removed the medium, Wash twice with PBS, add 500μL of diluted MTT solution (1mg/mL) to each well, cover the well plate with aluminum foil to protect from light, put it in the incubator for 30 minutes; finally remove the medium, wash twice with PBS, each Add 500μL DMSO to the well to dissolve the blue-violet nail (formazan) crystals, and finally use an immunoenzyme analyzer (ELISA) to determine the OD570 absorbance of the product.
細胞存活率(%)=(A/B)×100% Cell survival rate (%)=(A/B)×100%
A:樣品組於OD570之吸光值B:控制組於OD570之吸光值 A: The absorbance of the sample group at OD570 B: The absorbance of the control group at OD570
參照第14圖,控制組為未添加植物乳酸桿菌發酵物的萃取物,接著添加濃度1.32mg/mL、6.6mg/mL、13.2mg/mL之植物乳酸桿菌發酵物的萃取物反應24小時後之纖維母細胞存活率;由第14圖中可看出,當添加植物乳酸桿 菌發酵物的萃取物後,纖維母細胞存活率未有明顯改變,當濃度提高至13.2mg/mL時,纖維母細胞存活率略為下降,故可知在該等濃度下,尚未對細胞產生毒性。 Referring to Figure 14, the control group is the extract of the fermentation product of Lactobacillus plantarum without addition, followed by the addition of the extract of the fermentation product of Lactobacillus plantarum at a concentration of 1.32mg/mL, 6.6mg/mL, and 13.2mg/mL. The reaction is 24 hours later. Fibroblast survival rate; it can be seen from Figure 14 that when adding plant lactic acid rods The survival rate of fibroblasts did not change significantly after the extract of the bacterial fermentation product. When the concentration was increased to 13.2mg/mL, the survival rate of fibroblasts decreased slightly. Therefore, it can be seen that the cell has not been toxic at these concentrations.
參照第15圖,控制組為未添加過氧化氫(H2O2)、植物乳酸桿菌發酵物的萃取物及維生素E(Trolox),接著添加過氧化氫處理後,再依序添加濃度0.264mg/mL、1.32mg/mL、6.6mg/mL、13.2mg/mL、19.8mg/mL之植物乳酸桿菌發酵物的萃取物反應24小時以及維生素E(Trolox)之細胞存活率,為使圖式簡潔,圖中過氧化氫、植物乳酸桿菌及維生素E均以英文縮寫表示。 Refer to Figure 15, the control group is not added with hydrogen peroxide (H 2 O 2 ), the extract of the fermentation product of Lactobacillus plantarum, and vitamin E (Trolox), followed by the addition of hydrogen peroxide, followed by the addition of 0.264 mg. /mL, 1.32mg/mL, 6.6mg/mL, 13.2mg/mL, 19.8mg/mL of Lactobacillus plantarum fermentation extract for 24 hours and vitamin E (Trolox) cell survival rate, in order to make the diagram concise In the figure, hydrogen peroxide, Lactobacillus plantarum and Vitamin E are all expressed in English abbreviations.
由第15圖中可看出,經過氧化氫處理後之細胞存活率略為下降,但當添加植物乳酸桿菌發酵物的萃取物後,細胞存活率均明顯提高,當濃度提高至6.6mg/mL時,細胞存活率最高可提高至150%,且均較控制組細胞存活率高,由此可知在該等濃度下,尚未對細胞產生毒性。 It can be seen from Figure 15 that the cell survival rate after hydrogen oxide treatment decreased slightly, but when the extract of the fermentation product of Lactobacillus plantarum was added, the cell survival rate increased significantly, when the concentration was increased to 6.6 mg/mL , The cell survival rate can be increased up to 150%, and both are higher than the cell survival rate of the control group. It can be seen that at these concentrations, the cell has not yet been toxic.
實施例13:植物乳酸桿菌發酵物的萃取物之用途 Example 13: Use of extracts from fermentation products of Lactobacillus plantarum
參考實施例1至12所述植物乳酸桿菌發酵物的萃取物之實驗數據,其的確具有美白及抗氧化之功效,故可作為修復皮膚組成物之活性成分使用。修復皮膚組成物具體可為化妝品、保養品、防曬品等皮膚外用產品,該等皮膚外用產品可調配為下述形式:溶液、外用軟膏、乳膏、泡沫、營養護膚霜、柔軟護膚霜、敷料、軟水、乳液、打底霜、香精、肥皂、液體清潔劑、沐浴劑、防曬霜、防曬油、懸浮液、乳化物、糊、凝膠、洗劑、粉末、肥皂、含界面活性劑的清潔劑、油、粉狀粉底、乳化粉底、蠟狀粉底、貼片及噴霧,但不以上述為限。 With reference to the experimental data of the extract of the fermentation product of Lactobacillus plantarum described in Examples 1 to 12, it does have whitening and anti-oxidant effects, so it can be used as an active ingredient in a skin repair composition. The skin-repairing composition can specifically be cosmetics, skin care products, sunscreens and other external skin products. These external skin products can be formulated into the following forms: solution, external ointment, cream, foam, nutritional skin cream, soft skin cream, dressing , Soft water, lotion, base cream, essence, soap, liquid detergent, body wash, sunscreen, sunscreen oil, suspension, emulsion, paste, gel, lotion, powder, soap, cleaning with surfactant Agents, oils, powdered foundations, emulsified foundations, waxy foundations, patches and sprays, but not limited to the above.
從以上結果可以證實,本發明的植物乳酸桿菌(Lactobacillus plantarum,BCRC Number 10069)發酵物中分離所得之萃取物可以有效地防止黑色素形成,並具有良好的抗氧化能力,從而有效地美白皮膚、防止皮膚暗沉以及防止皮膚老化。 From the above results, it can be confirmed that the extract obtained from the fermentation of Lactobacillus plantarum (BCRC Number 10069) of the present invention can effectively prevent the formation of melanin, and has good antioxidant capacity, thereby effectively whitening the skin and preventing Dull skin and prevent skin aging.
本發明所屬技術領域者能夠自前述內容理解,本發明可藉由其他具體形式例式之而不改變本揭露內容之技術概念或本質特徵。就此而言,本文中揭露之例示性態樣係僅用於例示性說明之用,且不應解釋為限制本揭露內容之範疇。反之,本揭露內容係傾向於不僅涵蓋該等例示性態樣,亦涵蓋可包括於如後所附申請專利範圍定義者之本發明內容之精神及範疇內的多種變更、修飾、均等物、及其他態樣。 Those skilled in the art to which the present invention pertains can understand from the foregoing that the present invention can be implemented in other specific forms without changing the technical concepts or essential features of the disclosure. In this regard, the illustrative aspects disclosed in this article are for illustrative purposes only, and should not be construed as limiting the scope of the disclosure. On the contrary, the content of the present disclosure tends to cover not only these exemplary aspects, but also various changes, modifications, equivalents, and various changes, modifications, equivalents, and the spirit and scope of the content of the present invention that can be included in the definition of the scope of the patent application attached hereafter. Other aspects.
Claims (3)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW109123178A TWI748553B (en) | 2020-07-09 | 2020-07-09 | Skin repairing extract, composition containing the same and use thereof |
| CN202110506775.6A CN113925822A (en) | 2020-07-09 | 2021-05-10 | Extract for repairing skin, composition containing the same and use thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW109123178A TWI748553B (en) | 2020-07-09 | 2020-07-09 | Skin repairing extract, composition containing the same and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TWI748553B true TWI748553B (en) | 2021-12-01 |
| TW202202126A TW202202126A (en) | 2022-01-16 |
Family
ID=79274216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW109123178A TWI748553B (en) | 2020-07-09 | 2020-07-09 | Skin repairing extract, composition containing the same and use thereof |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN113925822A (en) |
| TW (1) | TWI748553B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115300441B (en) * | 2022-08-18 | 2023-10-27 | 美出莱(杭州)化妆品有限责任公司 | Fermented repair emulsion and preparation method and application thereof |
| TWI841127B (en) * | 2022-12-19 | 2024-05-01 | 弘光科技大學 | Combination containing coconut date kernel water extract and germ lactobacillus culture and use thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201821612A (en) * | 2016-12-12 | 2018-06-16 | 財團法人石材暨資源產業研究發展中心 | Method for preparing lactic acid bacteria culture solution and method for increasing free radical scavenging capacity of lactic acid bacteria using seawater taken from below 200 m sea level as starting material |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI480045B (en) * | 2012-09-17 | 2015-04-11 | Univ Hungkuang | Prevention and/or alleviation of alcoholic liver disease with a mixture of four lactic acid bacteria strains |
-
2020
- 2020-07-09 TW TW109123178A patent/TWI748553B/en active
-
2021
- 2021-05-10 CN CN202110506775.6A patent/CN113925822A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201821612A (en) * | 2016-12-12 | 2018-06-16 | 財團法人石材暨資源產業研究發展中心 | Method for preparing lactic acid bacteria culture solution and method for increasing free radical scavenging capacity of lactic acid bacteria using seawater taken from below 200 m sea level as starting material |
Non-Patent Citations (1)
| Title |
|---|
| 鄧逸琳等,"6種乳酸菌發酵液對皮膚抗氧化及美白功能的評價", 日用化學工業, 2020年5月, 50(5):325-330. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113925822A (en) | 2022-01-14 |
| TW202202126A (en) | 2022-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102124200B1 (en) | Cosmetic composition for antioxidation, skin-whitening and anti-wrinkle comprising fermented by-product of rice extracts its fractions as effective component | |
| KR102156898B1 (en) | Ingestible cosmetic composition for skin whitening, skin moisturizing, antioxidant, anti-inflammatory, skin barrier strengthening and skin absorption containing the lactic acid fermentation mixture | |
| KR102154927B1 (en) | A cosmetic composition for anti-aging, anti-oxidant, skin regeneration comprising chlorogenic acid, ferulic acid, resveratrol, and Streptococcus thermophilus fermented extract | |
| JP2015157773A (en) | cosmetic | |
| KR20180082056A (en) | A functional cosmetic composition comprising natural complex extract | |
| TWI748553B (en) | Skin repairing extract, composition containing the same and use thereof | |
| KR101176528B1 (en) | Cosmetic composition comprising the extract of salvia plebeia as active ingredient | |
| KR101435874B1 (en) | Cosmetic composition comprising extract Curcuma longa Linne leaf and manufacturing method thereof | |
| US20230104900A1 (en) | Cosmetic composition comprising fermented chestnut husk extract or fraction thereof as active ingredient | |
| KR20110122448A (en) | Cosmetic composition containing gelatin paste extract as an active ingredient | |
| KR102544792B1 (en) | Composition Comprising Complex Extract of seaweeds Fermented by Lactobacillus Brevis with Anti-Wrinkling and Elasticity, Antioxidant, and Skin Hydration Property as Active Ingredient | |
| JP2015157770A (en) | Cosmetics | |
| KR102710032B1 (en) | Cosmetic composition for antioxidation, skin-whitening and anti-wrinkle comprising rice by-product extracts fermented by lactic acid bacteria | |
| KR101445642B1 (en) | Cosmetic composition comprising the extract of Lagerstroemia indica as active ingredient | |
| KR100295875B1 (en) | Cosmetics Containing Green Bean Extract | |
| KR102698509B1 (en) | Cosmetic composition for antioxidation, skin-whitening and anti-wrinkle comprising fermented barley bran | |
| KR20180093560A (en) | A composition for skin whitening, anti-oxidating, astringent or anti-wrinkle comprising extracts of unripe plum | |
| KR20170089093A (en) | A cosmetic composition for antioxidating comprising extracts of eisenia bycyclis, gallnut and rhubarb | |
| KR100589484B1 (en) | Cosmetics Containing Situation Mushroom Extract | |
| KR101775485B1 (en) | Cosmetic composition containing fermentative extract of Spatholobus suberectus Dunn as active ingredient | |
| KR20020023168A (en) | Whitening Materials from Extracts of Gardenia Fruit | |
| KR102912025B1 (en) | Cosmetic composition comprising capelin egg and fermented herb extracts | |
| KR20180102892A (en) | Cosmetic composition for improving skin wrinkle comprising fermented extract of sonchus oleraceus | |
| WO2008156330A1 (en) | Use of xanthorrhizol for anti-wrinkle treatment | |
| JP2004203777A (en) | Ageing-preventing and improving cosmetic |